Gensec Bank and Real Africa, two South African investment groups, have launched the country's first venture capital biotechnology fund.

The fund, Bioventures, has initial capital of R40m (€5.6m) seeded by Gensec and Real Africa. A second closing will depend on the interest and appetite of institutional investors.